Cargando…
ANKHD1 promotes proliferation and invasion of non-small-cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway
The ankyrin repeat and KH domain-containing 1 (ANKHD1) protein was recently reported to be a potential member of the Hippo signaling pathway. However, its role in human non-small-cell lung cancer (NSCLC) has not been extensively investigated. The aim of the present study was to examine the expressio...
Autores principales: | Liu, Xiao-Fang, Han, Qiang, Rong, Xue-Zhu, Yang, Man, Han, Yu-Chen, Yu, Juan-Han, Lin, Xu-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115354/ https://www.ncbi.nlm.nih.gov/pubmed/32319569 http://dx.doi.org/10.3892/ijo.2020.4994 |
Ejemplares similares
-
Mask family proteins ANKHD1 and ANKRD17 regulate YAP nuclear import and stability
por: Sidor, Clara, et al.
Publicado: (2019) -
The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression
por: He, Chunbo, et al.
Publicado: (2015) -
The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023) -
Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5
por: Lu, Xu, et al.
Publicado: (2021) -
Scutellarin Inhibits Proliferation, Invasion, and Tumorigenicity in Human Breast Cancer Cells by Regulating HIPPO-YAP Signaling Pathway
por: Hou, Lengchen, et al.
Publicado: (2017)